Ortholevo is a Boston-based pharmaceutical startup founded on a track record of innovation to commercialize treatments for fibrotic diseases of joints, muscles, and connective tissues. Our mission is to improve the lives of millions of patients around the world by providing freedom from fibrosis.
Our technology safely and non-surgically treats fibrosis from neuromuscular diseases, musculoskeletal and congenital conditions, cosmetic ailments, inflammatory diseases, and many other pathologies. Having conducted proof-of-concept animal studies, we are now completing additional preclinical studies in preparation for a first-in-human clinical trial.
Contact: info@ortholevo.com
Company Details
- Employees
- 5
- Address
- Boston, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.ortholevo.com
- Keywords
- IT Consulting.
- HQ
- Boston
Ortholevo Questions
Ortholevo's website is http://www.ortholevo.com
Ortholevo's LinkedIn profile is https://www.linkedin.com/company/ortholevo
Ortholevo has
5 employees.
View email and phone details for 5
employees at Ortholevo.
Ortholevo's industry is
Pharmaceutical Manufacturing
Ortholevo's top competitors are
Techcologic,
Metaware Global,
Phagepro,
Ionic Pharmaceuticals,
Macrocycle Technologies,
Buckingham Home Private Limited,
Arytha Biosciences Llc,
Guardion, Inc.,
Maglick Core Technologies,
Articulate Biosciences.
Ortholevo's categories are Pharmaceutical Manufacturing
